item management s discussion and analysis of financial condition and results of operations the following discussion and analysis of the company s consolidated financial condition and consolidated results of operations should be read in conjunction with the company s consolidated financial statements and notes thereto included herein 
acquisition and joint venture strategies the company s results of operations in recent years have been significantly impacted by strategies and transactions undertaken by the company to expand its business  both domestically and internationally  in part to address significant changes in the healthcare industry  including potential national healthcare reform  trends toward managed care  cuts in medicare  consolidation of healthcare distribution companies and collective purchasing arrangements 
during the year ended december   the company completed nine acquisitions 
the completed acquisitions included general injectables and vaccines  inc giv  through the purchase of all of the outstanding common stock of biological popular culture  inc  and the international dental  medical and veterinary healthcare distribution businesses of heiland holding gmbh the heiland group 
giv  which had net sales of approximately million  is a leading independent direct marketer of vaccines and other injectable products to office based practitioners in the united states 
the heiland group  the largest direct marketer of healthcare supplies to office based practitioners in germany  had net sales of approximately million 
the acquisition agreements for giv and the heiland group provide for additional consideration of up to million per year through  not to exceed million in total  and million per year through  respectively  to be paid if certain sales and profitability targets are met 
the giv acquisition agreement also provides for additional consideration of million based upon sales of new products  as defined 
the remaining seven acquisitions had combined net sales of approximately million for six of the acquisitions were accounted for under the purchase method of accounting  while the remaining acquisition was accounted for under the pooling of interests method of accounting 
results of operations of the business acquisitions accounted for under the purchase method of accounting have been included in the consolidated financial statements commencing with the acquisition dates 
the total cash purchase price paid for the acquisitions accounted for under the purchase method of accounting was approximately million 
the excess of the acquisition costs over the fair value of identifiable assets will be amortized on a straight line basis over years 
the pooling transaction was not material and has been included in the consolidated financial statements from the beginning of the quarter in which the acquisition occurred 
the company issued  shares of its common stock with an aggregate market value of million in connection with the pooling transaction 
during the year ended december   the company completed five acquisitions 
the completed acquisitions included two dental supply companies  the most significant of which was meer  a leading full service dental distributor serving dentists  dental laboratories and institutions throughout the united states  with annual net sales of approximately million 
combined  meer and the other dental company had approximately million in aggregate net sales for the completed acquisitions also included two medical supply companies with aggregate net sales for of approximately million  and one international dental distribution business with net sales of approximately million 
of the five completed acquisitions  four including meer were accounted for under the pooling of interests method  and the remaining acquisition of a interest was accounted for under the purchase method of accounting 
the financial statements were restated to give retroactive effect to the meer transaction  as the remaining three pooling transactions were not material and have been included in the consolidated financial statements from the beginning of the quarter in which the acquisitions occurred 
results of operations of the business acquisition accounted for under the purchase method of accounting have been included in the consolidated financial statements commencing with the acquisition date 
the company issued  shares   shares and  shares of its common stock  with an aggregate value of approximately million in connection with three of the pooling transactions 
prior to its acquisition by the company  meer elected to be treated as an s corporation under the internal revenue code  and accordingly  was not subject to taxation at the corporate level 
pro forma adjustments have been made to reflect a provision for income taxes for each period presented and the elimination of a deferred tax benefit arising from meer s conversion from the s corporation to a c corporation 
additionally  in connection with one of the dental supply company acquisitions accounted for under the pooling of interests method of accounting  the company issued shares of a subsidiary  with rights equivalent to those of the company s common stock  which are exchangeable into  shares of the company s common stock  at each shareholders option  and had an aggregate value of approximately million 
the total cash purchase price for the acquisition accounted for under the purchase method of accounting was approximately million 
the excess of the acquisition costs over the fair value of identifiable net assets acquired are being amortized on a straight line basis over years 
during the year ended december   the company acquired in pooling of interests transactions  all of the outstanding common stock of i sullivan  a distributor of consumable dental supplies and equipment  ii mbmi  a distributor of medical supplies and iii dentrix  a leading provider of clinically based dental practice management systems 
prior to its acquisition of the company  dentrix elected to be treated as an s corporation under the internal revenue code  and accordingly  its earnings were not subject to taxation at the corporate level 
pro forma adjustments have been made to reflect a provision for income taxes on such previously untaxed earnings for each period presented 
in addition to these three acquisitions  the company completed other acquisitions including  three medical and ten dental supply companies with aggregate net sales for of approximately million and million  respectively  two international dental and three international medical supply companies with aggregate net sales for of approximately million and million  respectively  two technology and other value added product companies with aggregate net sales for of approximately million  and certain assets and the business of ide interstate  inc  a direct marketer of healthcare products to dentists  doctors and veterinarians with net sales for of approximately million 
of the twenty four completed acquisitions  six were accounted for under the pooling of interests method of accounting  with the remainder being accounted for under the purchase method of accounting fifteen for ownership interests and three for majority ownership interests 
the financial statements were restated to give retroactive effect to three of the pooling transactions sullivan  mbmi and dentrix as the remaining three pooling transactions were not material and were included in the consolidated financial statements from the beginning of the quarter in which the acquisitions occurred 
operations of the completed acquisitions  accounted for under the purchase method of accounting  were included in the consolidated financial statements from their respective acquisition dates 
in connection with the  and acquisitions  the company incurred certain merger and integration costs of approximately million  million and million  respectively 
net of taxes  merger and integration costs were approximately  and per share  on a diluted basis  respectively 
merger and integration costs for the healthcare distribution and technology segments were million and million for  million and million for and million and million for  respectively 
merger and integration costs consist primarily of investment banking  legal  accounting and advisory fees  compensation  impairment of goodwill arising from acquired businesses integrated into the company s medical and dental businesses  as well as certain other integration costs associated with these mergers 
excluding the merger and integration costs  and including pro forma adjustments  pro forma net income and pro forma net income per common share  on a diluted basis  would have been million and  respectively  for the year ended december   million and  respectively  for the year ended december   and million and  respectively  for the year ended december  the company is a party to a number of claims  suits and complaints arising in the ordinary course of business  as described in legal proceedings 
in the opinion of the company  all such pending matters are covered by insurance or are of such kind  or involve such amounts  as would not have a material adverse effect on the financial statements of the company if disposed of unfavorably 
results of operations the following table sets forth for the periods indicated net sales  gross profit and operating profit  excluding merger and integration costs  in thousands by business segment for the years ended  and net sales by segment data healthcare distribution dental    medical    veterinary    international    total healthcare distribution    technology    total    gross profit by segment data healthcare distribution    technology    total    adjusted operating profit excluding merger and integration costs by segment data healthcare distribution 
   technology    total    dental consists of the company s dental business in the united states and canada 
international consists of the company s business primarily dental outside the united states and canada  primarily in europe  and australia 
technology consists of the company s practice management software business and certain other value added products and services 
excludes merger and integration costs of million  million and million in  and  respectively 
excludes merger and integration costs of million and million in and  respectively 
compared to net sales increased million  or  to  million in from  million in of the million increase  approximately million  or  represented an increase in the company s healthcare distribution business 
as part of this increase  approximately million represented a increase in its medical business  million represented a increase in its international business  million represented a increase in the company s veterinary business  and million represented a decrease in the company s dental business 
the increase in medical net sales is primarily attributable to telesales and direct marketing activities  acquisitions  and increased sales to hospitals 
in the international market  the increase in net sales was primarily due to acquisitions in germany and the united kingdom  and increased account penetration in the united kingdom  belgium  spain and france 
in the veterinary market  the increase in net sales was primarily due to increased account penetration 
the decrease in dental net sales was primarily due to sales erosion related to the meer acquisition and a reduction in dental equipment sales 
the remaining increase in net sales was due to the technology business  which increased million  or  to million for  from million for the increase in technology and value added product sales was primarily due to increased practice management software sales and an acquisition 
gross profit increased by million  or  to million in  from million in gross profit margin for healthcare distribution decreased by to from last year 
healthcare distribution gross profit increased by million  or  to million in  from million in gross profit margin decreased by  to  from last year primarily due to sales mix and lower manufacturers rebates as a result of reduced annual sales 
technology gross profit increased by million  or  to million in  from million in technology gross profit margin decreased by to from last year primarily due to changes in sales mix 
selling  general and administrative expenses increased by million  or  to million in from million in selling and shipping expenses increased by million  or  to million in from million in as a percentage of net sales  selling and shipping expenses decreased to in from in this decrease was primarily due to improvement in the company s distribution efficiencies resulting from the leveraging of the company s distribution infrastructure 
general and administrative expenses increased million  or  to million in from million in  primarily as a result of acquisitions 
as a percentage of net sales  general and administrative expenses remained constant at in and other income expense net changed by million  to million for the year ended december  from million for due to an increase in interest expense resulting from an increase in average borrowings and to a lesser extent an increase in interest rates  offset by higher interest income on notes receivable and accounts receivable balances 
equity in earnings losses of affiliates decreased million or  to million in from million in the decline was due to reduced earnings from an affiliate totaling approximately million  net of taxes  due to a temporary cessation of production of anesthetic products produced by hs pharmaceutical 
hs pharmaceutical is an affiliated company  which is accounted for under the equity method 
on september   the fda issued clearance to hs pharmaceutical to resume production of its anesthetic products for shipment into the united states 
hs pharmaceutical resumed limited production and shipment of its products in the fourth quarter of for  the company s effective tax rate was 
excluding merger and integration costs  the majority of which are not deductible for income tax purposes  the company s effective tax rate would have been 
the difference between the company s effective tax rate  excluding merger and integration costs  and the federal statutory rate relates primarily to state income taxes 
for the company s effective tax rate was 
excluding merger and integration costs  the majority of which are not deductible for income tax purposes  and including a proforma tax adjustment for meer on previously untaxed earnings as an s corporation  combined with the elimination of a net deferred tax asset arising from meer s conversion from an s corporation to a c corporation  the company s effective tax rate would have been 
the difference between the company s effective tax rate  excluding merger and integration costs and the meer tax adjustment  and the federal statutory rate relates primarily to state income taxes 
compared to net sales increased million  or  to  million in from  million in of the million increase  approximately million or represented a increase in the company s healthcare distribution business 
as part of this increase  approximately million represented a increase in the company s dental business  million represented a increase in its medical business  million represented a increase in its international business and million represented a increase in the company s veterinary business 
the increase in dental net sales was primarily the result of the continuing favorable impact of the company s integrated sales and marketing approach which coordinates the efforts of its field sales consultants with its direct marketing and telesales personnel  continued success in the company s target marketing programs and purchase acquisitions  offset in part by a reduction in dental equipment sales resulting from the company s disposal of its equipment manufacturing subsidiary  marus dental international marus  in august and estimated sales erosion on the meer acquisition 
the increase in medical net sales is primarily attributable to sales to hospitals  acquisitions and the benefits of a new telesales structure  partially offset by a decline in sales to renal dialysis centers 
in the first quarter of the company s largest renal dialysis customer  renal treatment centers  inc rtc  was acquired by total renal care  inc which is not a customer of the company 
in march of  rtc stopped purchasing epogen from the company  but continues to purchase other products 
during fiscal year  the company s sales of epogen to rtc amounted to million 
in the international market  the increase in net sales was due to increased account penetration in france  the united kingdom and spain and acquisitions  primarily in germany  the united kingdom and the netherlands 
in the veterinary market  the increase in net sales was primarily due to increased account penetration with core accounts and veterinary groups 
excluding net sales of marus and rtc in both periods  as well as the estimated sales erosion on the meer acquisition  healthcare distribution net sales would have grown by in over the remaining increase in net sales was due to the technology business  which increased million or to million for  from million for the increase in technology and value added product sales was primarily due to increased practice management software sales 
gross profit increased by million  or  to million in  from million in gross profit margin increased by to from last year 
healthcare distribution gross profit increased by million or to million in  from million in healthcare distribution gross profit margin increased by to from last year primarily due to sales mix 
technology gross profit increased by million or to  million in  from million in technology gross profit margin increased by to from last year primarily due to increased sales volume of software systems 
selling  general and administrative expenses increased by million  or  to million in from million in selling and shipping expenses increased by million  or  to million in from million in as a percentage of net sales  selling and shipping expenses decreased to in from in this decrease was primarily due to leveraging of the company s distribution infrastructure 
general and administrative expenses increased million  or  to million in from million in  primarily as a result of acquisitions 
as a percentage of net sales  general and administrative expenses increased in  to from in other income expense net decreased by million  to million for the year ended december  from million for due to an increase in interest expense resulting from an increase in average borrowings and lower imputed interest income on long term accounts receivable balances 
equity in earnings of affiliates decreased million or to million in from million in the decline is the result of the reduced earnings in the fourth quarter of an affiliate due to a voluntary recall of anesthetic products produced by novocol 
for  the company s effective tax rate was 
excluding merger and integration costs  the majority of which are not deductible for income tax purposes  and including a proforma tax adjustment for meer on previously untaxed earnings as an s corporation  combined with the elimination of a net deferred tax asset arising from meer s conversion from an s corporation to a c corporation  the company s effective tax rate would have been 
the difference between the company s effective tax rate  excluding merger and integration costs and the meer tax adjustment  and the federal statutory rate relates primarily to state income taxes 
for  the company s effective tax rate was 
on a pro forma basis  adjusting for assumed tax benefits arising from the losses of meer as an s corporation  and excluding merger and integration costs  the majority of which are not deductible for income tax purposes  the company s effective tax rate would have been 
the difference between the effective tax rate excluding merger and integration costs and the federal statutory rate relates primarily to state income taxes 
year during the fourth quarter of the company completed its company wide program to prepare its computer systems  applications and software products for the year the cost of this program was approximately million  with approximately million representing incremental costs to the company 
subsequent to december   the company has not experienced any year problems either internally or from suppliers or other outside sources that had an adverse impact on the company s operations or financial condition 
the company has no reason to believe that year failures will materially affect it in the future 
however  since it may take several additional months before it is known whether the company or suppliers  vendors or customers may have undergone year problems  no assurances can be given that the company will not experience losses or disruptions due to year computer related problems 
the company will continue to monitor the operation of its software products  computers and microprocessor based devices for any year problems 
euro conversion effective january   of the member countries of the european union have adopted the euro as their common legal currency 
on that date  the participating countries established fixed euro conversion rates between their existing sovereign currencies and the euro 
the euro now trades on currency exchanges and is available for non cash transactions 
the participating countries now issue sovereign debt exclusively in euros  and have re denominated outstanding sovereign debt 
the authority to direct monetary policy for the participating coutnries  including money supply and official interest rates for the euro  is now exercised by the new european central bank 
in  the company established a euro task force to address its information system  product and customer concerns 
the company expects to achieve timely euro information system and product readiness  so as to conduct transactions in the euro  in accordance with implementation schedules as they are established by the european commission 
the company does not anticipate that the costs of the overall effort will have a material adverse impact on future results 
inflation management does not believe inflation had a material adverse effect on the financial statements for the periods presented 
effect of recently issued accounting standards in june  the financial accounting standards board fasb issued statement of financial accounting standards no 
fas  accounting for derivative instruments and hedging activities 
in may  the fasb voted to delay the effective date of fas by one year 
the company will be required to adopt fas for transactions entered into for quarters in the fiscal year beginning after december  fas requires that all derivative instruments be recorded on the balance sheet at fair value 
changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income  depending on whether a derivative is designated as part of the hedge transaction and the type of hedge transaction 
the ineffective portion of all hedges will be recognized in earnings 
the company is in the process of determining the impact that the adoption of fas will have on its results of operations and financial position 
risk management the company has operations in the united states  canada  mexico  the united kingdom  the netherlands  belgium  germany  france  the republic of ireland  austria  spain  israel  australia and new zealand 
substantially all of the company s operations endeavor to protect margins by using foreign currency forward contracts to hedge the estimated foreign currency payments to foreign vendors 
the total us dollar equivalent of all foreign currency forward contracts hedging debt and the purchase and sale of merchandise was million as of the fiscal year end 
the company considers its investment in foreign operations to be both long term and strategic 
as a result  the company does not hedge the long term translation exposure to its balance sheet 
the company has experienced negative translation adjustments of approximately million and million in and  respectively  which adjustments were reflected in the balance sheet as an adjustment to stockholders equity 
the cumulative translation adjustment at the end of showed a net negative translation adjustment of million 
the company has a canadian subsidiary which purchases in us dollars  some of the products it sells locally in canadian dollars 
in order to minimize its exposure to fluctuations in us dollar canadian dollar exchange rates  the company  in november and december  entered into foreign currency forward contracts with major international banks to fix the exchange rate at which it buys some of its year us dollar denominated products 
under these agreements  the company has obligations to buy approximately million us dollars at predetermined fixed rates 
the company anticipates entering into new such contracts in the normal course of business 
in october  the company entered into a netherlands guilder nlg loan in the amount of million nlg 
the loan serves to hedge the repayment of an intercompany loan in the same amount  denominated in nlg  due from a dutch subsidiary 
the nlg loan calls for periodic payments and a balloon payment of million nlg in january the company had entered into two interest rate swaps with major financial institutions to exchange variable rate interest for fixed rate interest 
the net result was to substitute a weighted average fixed interest rate of for the variable libor rate on million of the company s debt 
the interest rate swaps expire in december and november liquidity and capital resources the company s principal capital requirements have been to fund a repayments on bank borrowings  b acquisitions  c capital expenditures  and d working capital needs resulting from increased sales  special inventory forward buy in opportunities and to fund initial start up inventory requirements for new distribution centers 
since sales have been strongest during the fourth quarter and special inventory forward buy in opportunities are most prevalent just before the end of the year  the company s working capital requirements have been generally higher from the end of the third quarter to the end of the first quarter of the following year 
the company has financed its business primarily through its revolving credit facilities  private placement loans and stock issuances 
net cash provided by operating activities for the year ended december  of million resulted primarily from net income of million  increased by non cash charges relating primarily to depreciation and amortization of million  offset by a net use of working capital of million 
the use of working capital was primarily due to a decrease in accounts payable and other accrued expenses of million  and an million increase in accounts receivable resulting primarily from increased net sales and a decrease in the percentage of customers who make payment with their orders  offset in part by an million decrease in inventories  and a million decrease in other current assets 
the company anticipates future uses of working capital as a result of its continued sales growth  and special inventory forward buy in opportunities 
net cash used in investing activities for the year ended december  of million resulted primarily from cash used to make acquisitions of million and capital expenditures of million 
during the past three years  the company has invested million in the development of new computer systems  and expenditures for new and existing operating facilities 
in the coming year  the company expects to invest in excess of million per year in capital projects to modernize and expand its facilities and infrastructure systems and integrate operations 
net cash provided by financing activities for the year ended december  of million resulted primarily from cash proceeds from borrowings and issuance of stock of approximately million offset primarily by debt repayments of approximately million 
certain holders of minority interests in acquired entities or ventures have the right at certain times to require the company to acquire their interest at either fair market value or a formula price based on earnings of the entity 
the company s cash and cash equivalents as of december  of million consist of bank balances and investments in commercial paper rated aaa by moody s or an equivalent rating 
these investments have staggered maturity dates  none of which exceed three months  and have a high degree of liquidity since the securities are actively traded in public markets 
the company entered into an amended revolving credit facility on august  that increased its main credit facility to million and extended the facility termination date to august  borrowings under the credit facility were million at december  the company also has one uncommitted bank line totaling million  none of which had been borrowed at december  on june  and september   the company completed private placement transactions under which it issued million and million  respectively  in senior notes  the proceeds of which were used respectively  for the permanent financing of its acquisitions of giv and heiland  as well as repaying and retiring a portion of four uncommitted bank lines and to pay down amounts owed under its revolving credit facility 
the million notes come due on june  and bear interest at a rate of per annum 
principal payments totaling million are due annually starting september  for the million notes and bear interest at a rate of per annum 
interest is payable semi annually 
certain of the company s subsidiaries have credit facilities that totaled million at december  under which million had been borrowed 
the aggregate purchase price of the acquisitions completed during  including the acquisition of the minority interests of two subsidiaries  was approximately million  payable million in cash and million in stock 
the acquisitions of giv and the heiland group were funded by the company s revolving credit agreement and various short term borrowings entered into in january existing borrowing lines primarily funded the remaining cash portion of the purchases 
the company believes that its cash and cash equivalents of million as of december   its ability to access public and private debt and equity markets  and the availability of funds under its existing credit agreements will provide it with sufficient liquidity to meet its currently foreseeable short term and long term capital needs 
item a 
market risk s the company is exposed to market risks  which include changes in us and international interest rates as well as changes in foreign currency exchange rates as measured against the us dollar and each other 
the company attempts to reduce these risks by utilizing financial instruments  pursuant to company policies 
the value of the us dollar affects the company s financial results 
changes in exchange rates may positively or negatively affect the company s revenues as expressed in us dollars  gross margins  operating expenses  and retained earnings 
where the company deems it prudent  it engages in hedging programs aimed at limiting in part the impact of currency fluctuations 
using primarily forward exchange contracts  the company hedges those transactions that  when remeasured according to generally accepted accounting principles  impact the income statement 
from time to time  the company purchases short term forward exchange contracts to protect against currency exchange risks associated with the anticipated revenue of the company s international subsidiaries 
as of december   the company has outstanding foreign currency forward contracts aggregating million related to debt and the purchase and sale of merchandise 
the contracts hedge against currency fluctuations of deutsche mark million  british pounds million  swiss francs million and australian dollars million 
at december   the company had net deferred losses from foreign currency forward contracts of million 
the contracts expire at various dates through february these hedging activities provide only limited protection against currency exchange risks 
factors that could impact the effectiveness of the company s programs include volatility of the currency markets  and availability of hedging instruments 
all currency contracts that are entered into by the company are components of hedging programs and are entered into for the sole purpose of hedging an existing or anticipated currency exposure  not for speculation 
although the company maintains these programs to reduce the impact of changes in currency exchange rates  when the u 
s 
dollar sustains a strengthening position against currencies in which the company sells products and services or a weakening exchange rate against currencies in which the company incurs costs  the company s revenues or costs are adversely affected 
as of december   the company had million outstanding in interest rate swaps 
these swaps are used to convert floating rate debt relating to the company s revolving credit agreement  to fixed rate debt to reduce the company s exposure to interest rate fluctuations 
the net result was to substitute a weighted averaged fixed interest rate of for the variable libor rate on million of the company s debt 
the swaps expire in december and december under the interest rate environment during the year ended december   the net fair value of the company s interest rate swap agreements resulted in a recognized loss of approximately million 

